Price Alert

OraSure Technologies Inc. (OSUR)

NASDAQ: OSUR · Real-Time Price · USD

2.77

-0.08 (-2.81%)

At close: Aug 14, 2025, 3:59 PM

2.75

-0.71%

After-hours: Aug 14, 2025, 06:51 PM EDT

-2.81% (1D)

Bid	2.65
Market Cap	202.59M
Revenue (ttm)	38.67M
Net Income (ttm)	-51.03M
EPS (ttm)	-0.68
PE Ratio (ttm)	-4.07
Forward PE	-4.57
Analyst	Hold

Ask	2.86
Volume	446,517
Avg. Volume (20D)	756,958
Open	2.82
Previous Close	2.85
Day's Range	2.74 - 2.88
52-Week Range	2.36 - 4.61
Beta	0.27

About OSUR

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol OSUR

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for OSUR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

OraSure has released their quartely earnings on Aug 5, 2025:

Revenue of $31.24M exceeds estimates by $2.23M, with -42.50% YoY decline.

EPS of -0.19 misses estimates by -0.02, with -371.43% YoY decline.

Next Earnings Release

OraSure Technologies Inc. is scheduled to release its earnings on Nov 5, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

4 months ago

+6.4%

OraSure Technologies shares are trading higher aft... Unlock content with Pro Subscription

5 months ago

-23.5%

OraSure Technologies shares are trading lower after the company issued Q1 revenue guidance below estimates.

News

1 week ago · fool.com

OraSure (OSUR) Q2 Revenue Falls 43%

1 week ago · seekingalpha.com

OraSure Technologies, Inc. (OSUR) Q2 2025 Earnings Call Transcript

OraSure Technologies, Inc. (NASDAQ:OSUR ) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants Carrie Eglinton Manner - President, CEO & Director Jason Michael Plagman - Vic...

1 week ago · zacks.com

OraSure Technologies (OSUR) Reports Q2 Loss, Beats Revenue Estimates

OraSure Technologies (OSUR) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to earnings of $0.07 per share a year ago.

2 weeks ago · seekingalpha.com

OraSure Technologies: An Asymmetric Bet

OraSure trades near cash value with minimal debt, reflecting excessive market pessimism and creating an asymmetric risk-reward opportunity. The company's future hinges on Sherlock's at-home STD test k...

1 month ago · reuters.com

OraSure Technologies received takeover bid from industry entrepreneur, sources say

Prominent healthcare entrepreneur Ron Zwanziger approached medical device maker OraSure Technologies with a takeover offer, three people familiar with the matter said, in what would mark more consolid...

2 months ago · seekingalpha.com

Orasure Technologies: Multiple Shots To Deliver Value

OSUR remains deeply undervalued, trading below liquidation value, with a robust, cash-rich, debt-free balance sheet providing downside protection. Key value drivers include a 20% share buyback, potent...